Icosapent Ethyl Reduces Ischemic Events in Patients With a History of Previous Coronary Artery Bypass Grafting: REDUCE-IT CABG.
Subodh VermaDeepak L BhattPhillippe Gabriel StegMichael MillerEliot A BrintonTerry A JacobsonNitish K DhingraSteven B KetchumRebecca A JulianoLixia JiaoRalph T DoyleCraig GranowitzC Michael GibsonDuane PintoRobert P GiuglianoMatthew J BudoffR Preston MasonJean Claude TardifChristie M Ballantynenull nullPublished in: Circulation (2021)
In REDUCE-IT patients with a history of coronary artery bypass grafting, treatment with icosapent ethyl was associated with significant reductions in first and recurrent ischemic events. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01492361.